Scherman, Daniel
Inserm,
France
2024 Rank: 146667
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biotechnology
Rank in SubField 1: 1026 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 146667 | 167734 |
| Total Cites | 967 | 1055 |
| H-index | 13 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 29 | 29 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 200 | 210 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 780 | 808 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.31 |
| Self-Citation Percentage |
8.34%
|
|
Scherman, Daniel
Unité de Technologies Chimiques et Biologiques pour la Santé,
France
2023 Rank: 138645
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biotechnology
Rank in SubField 1: 988 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 138645 | 162733 |
| Total Cites | 1027 | 1107 |
| H-index | 14 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 27 | 27 |
| Number of Single+First+Last Authored Papers | 124 | 124 |
| Total Cites to Single+First+Last Authored Papers | 211 | 216 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 840 | 869 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.27 |
| Self-Citation Percentage |
7.23%
|
|
Scherman, Daniel
Université Paris Cité,
France
2022 Rank: 174800
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biotechnology
Rank in SubField 1: 1338 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 174800 | 186531 |
| Total Cites | 1021 | 1117 |
| H-index | 12 | 13 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 27 | 27 |
| Number of Single+First+Last Authored Papers | 124 | 124 |
| Total Cites to Single+First+Last Authored Papers | 203 | 211 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 767 | 806 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.39 |
| Self-Citation Percentage |
8.59%
|
|
Scherman, Daniel
Université de Paris,
France
2021 Rank: 186183
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biotechnology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 878 out of 52513 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 186183 | 204994 |
| Total Cites | 1548 | 1726 |
| H-index | 15 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 33 | 33 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 306 | 321 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1189 | 1251 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.38 |
| Self-Citation Percentage |
10.31%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.